Cytek Biosciences, Inc.CTKBNASDAQ
Loading
EBITDA as a percentage of revenue
Percentile
P17
Within normal range
vs 5Y Ago
-0.5x
Contraction
Streak
5 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -8.63% | -72.5% |
| 2024 | -5.01% | -119.2% |
| 2023 | -2.28% | -139.5% |
| 2022 | 5.79% | -17.0% |
| 2021 | 6.97% | -57.9% |
| 2020 | 16.55% | +159.9% |
| 2019 | -27.61% | - |